Shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $11.82 and traded as low as $11.61. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München shares last traded at $12.23, with a volume of 562,518 shares.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on the stock. Barclays raised shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "strong-buy" rating in a research note on Tuesday, January 28th. UBS Group lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research report on Thursday, December 19th. Finally, The Goldman Sachs Group lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Four investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München presently has a consensus rating of "Hold".
Read Our Latest Stock Analysis on MURGY
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance
The company has a market cap of $87.85 billion, a P/E ratio of 8.54, a P/E/G ratio of 1.72 and a beta of 0.79. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.12 and a current ratio of 1.12. The stock has a 50-day simple moving average of $11.94 and a 200 day simple moving average of $10.96.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) last announced its earnings results on Wednesday, February 26th. The financial services provider reported $0.16 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.01). The business had revenue of $16.34 billion during the quarter, compared to analyst estimates of $19.10 billion. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a net margin of 8.61% and a return on equity of 18.94%. On average, equities analysts expect that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 0.46 EPS for the current year.
About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
(
Get Free Report)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
See Also
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.